|
|
Blood, 15 August 2004, Vol. 104, No. 4, pp. 1017-1024.
Prepublished online as a Blood First Edition Paper on May 6, 2004; DOI 10.1182/blood-2004-02-0419.
 Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Megakaryocytes express functional Aurora-B kinase in endomitosis
Amy E. Geddis, and
Kenneth Kaushansky
From the Departments of Pediatrics and Medicine, University of California San Diego (UCSD), La Jolla, CA.
Endomitosis (EnM) in megakaryocytes (MKs) is characterized by abortion of mitosis in late anaphase and failure of cytokinesis; subsequent reinitiation of DNA synthesis results in polyploidy. Ablation of chromosomal passenger proteins including Aurora-B kinase causes defects in late anaphase and cytokinesis in diploid cells; thus one hypothesis is that the expression or function of these proteins in polyploid MKs is abnormal. It has been reported that Aurora-B kinase mRNA is decreased in polyploid megakaryocytic cells, suggesting that deficiency of Aurora-B kinase is responsible for EnM. We examined the localization of Aurora-B kinase and additional members of the chromosomal passenger protein and aurora kinase families in MKs. We found that in EnM MKs (1) Aurora-B kinase is present and appropriately localized to centromeres in early EnM; (2) in low-ploidy human MKs, centromeric localization of survivin and inner centromere protein (INCENP) can also be demonstrated; (3) the function of Aurora-B kinase, as measured by Ser10 phosphorylation of histone H3, is intact; and (4) aurora-A kinase localizes appropriately to centrosomes in EnM. These results suggest that EnM MKs appropriately express functional Aurora-B kinase and related proteins in early anaphase, making a simple deficiency of this protein an unlikely explanation for polyploidy in this cell type.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
Q. Wen, C. Leung, Z. Huang, S. Small, A. L. Reddi, J. D. Licht, and J. D. Crispino
Survivin is not required for the endomitotic cell cycle of megakaryocytes
Blood,
July 2, 2009;
114(1):
153 - 156.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Walsby, V. Walsh, C. Pepper, A. Burnett, and K. Mills
Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts
Haematologica,
May 1, 2008;
93(5):
662 - 669.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. McCrann, T. Yezefski, H. G. Nguyen, N. Papadantonakis, H. Liu, Q. Wen, J. D. Crispino, and K. Ravid
Survivin overexpression alone does not alter megakaryocyte ploidy nor interfere with erythroid/megakaryocytic lineage development in transgenic mice
Blood,
April 15, 2008;
111(8):
4092 - 4095.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. S. Hitchcock, N. E. Fox, N. Prevost, K. Sear, S. J. Shattil, and K. Kaushansky
Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout
Blood,
January 15, 2008;
111(2):
596 - 604.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Fukuda and L. M. Pelus
Survivin, a cancer target with an emerging role in normal adult tissues
Mol. Cancer Ther.,
May 1, 2006;
5(5):
1087 - 1098.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. G. Muntean and J. D. Crispino
Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development
Blood,
August 15, 2005;
106(4):
1223 - 1231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Gurbuxani, Y. Xu, G. Keerthivasan, A. Wickrema, and J. D. Crispino
Differential requirements for survivin in hematopoietic cell development
PNAS,
August 9, 2005;
102(32):
11480 - 11485.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Lannutti, N. Blake, M. J. Gandhi, J. A. Reems, and J. G. Drachman
Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656
Blood,
May 15, 2005;
105(10):
3875 - 3878.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
